SÖSelda Özgen

Selda Özgen

*This is an algorithmically generated author record based on publicly available information.

Selda Özgen has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    In Silico ADME Screening and Evaluation of Antimicrobial and Antimycobacterial Activities of 3,5-Diphenyl Pyrazoline Derivatives

    by Begüm Evranos Aksöz, Fatma Kaynak Kaynak Onurdağ, Erkan Aksöz, Selda Özgen

    Objective: The unconscious widespread use of antibiotics leads to the development of resistance to antibiotics. When resistance to an antibiotic develops, it now either shows less efficacy or loses its effect completely at that antibiotic treatment dose. While the development of resistance to antibiotics increases rapidly, the need for the development of new antibiotics rises every day. For this purpose, in this study, antimicrobial and antitubercular effects of some compounds in the pyrazoline structure were investigated. The physicochemical properties and drug-likeness of the compounds are quite important for determining whether a compound can be used as a drug or not. Physicochemical properties and drug-likeness of the synthesized compounds were evaluated and the relevance for Lipinski’s rules was determined. Material-Method: Drug-likeness properties of the synthesized compounds were determined using online Swiss ADME tool. Antitubercular activity is detected by microplate alamar blue assay. Antimicrobial activity is tested by microdilution method. Results: All compounds obeyed the Lipinski’s rules, some of with no violation, some of with one violation. Compounds B7, B10 and B11 provided Lipinski’s rules with one violation. Other compounds ensured Lipinski’s rules with no violation. All compounds were predicted to have high gastrointestinal absorption. As the compounds generally have high lipophilicity, it was predicted that all compounds except B12 can cross the blood brain barrier. Conclusion: Synthesized compounds were mostly found to be more effective against Enterococcus faecalis, Enterococcus faecalis isolate and Candida albicans. Compound B10 demonstrated the best antimicrobial activity against Enterococcus faecalis isolate with a 16µg/mL MIC value.


  • Open Access

    Investigation of Antimicrobial and Antitubercular Activities of Some Hydrazone Derived Compounds

    by Begüm Evranos Aksöz Aksöz, Fatma Kaynak Kaynak Onurdağ Onurdağ, Erkan Aksöz, Selda Özgen

    Tr en Bir seri hidrazon türevi, antifungal, antimikrobiyal ve antitüberküler etkilerini araştırmak için sentezlendi. Bileşiklerin bu etkileri, Escherichia coli, Escherichia coli izolat (ESBL), Pseudomonas aeruginosa, Pseudomonas aeruginosa izolat (gentamisine dirençli), Staphylococcus aureus, Staphylococcus aureus izolat (MRSA), Enterococcus faecalis, Enterococcus faecalis izolat (VRE), Candida albicans, Candida krusei ve Mycobacterium tuberculosis karşısında araştırıldı. Sentez edilen bileşiklerden B23 Candida albicans karşısında 16 µg/mL MİK değeri ile, B24 ise Staphylococcus aureus izolatı (MRSA) karşısında 16 µg/mL MİK değeri ile en iyi etkiyi gösterdi. Mycobacterium tuberculosis karşısında en etkin bileşiğin ise 32 µg/mL MİK değeri ile bir şalkon türevi olan E9 olduğu bulundu. Bununla birlikte, tüm bileşiklerin Escherichia coli ve Escherichia coli isolat karşısında etkisiz olduğu saptandı. A series of hydrazone derivatives were synthesized to investigate antifungal, antimicrobial and antitubercular activities. These activities were investigated against Escherichia coli, Escherichia coli isolate, Pseudomonas aeruginosa, Pseudomonas aeruginosa isolate (resistant to gentamicin), Staphylococcus aureus, Staphylococcus aureus isolate (MRSA), Enterococcus faecalis, Enterococcus faecalis isolate (VRE), Candida albicans, Candida krusei and Mycobacterium tuberculosis. Among the synthesized compounds B23 had the best activity against Candida albicans with 16 µg/mL MIC value and B24 had the best activity against Staphylococcus aureus isolate (MRSA) with 16 µg/mL MIC value. The most effective compound against Mycobacterium tuberculosis is found to be E9 with 32 µg/mL MIC value, a chalcone derivative. However, all compounds were determined as ineffective against Escherichia coli and Escherichia coli isolate.

  • Open Access

    Novel Benzoxazoles: Synthesis and Antibacterial, Antifungal, and Antitubercular Activity against Antibiotic-Resistant and -Sensitive Microbes

    by Mustafa Arisoy, Ozlem Temiz-Arpaci, Fatma Kaynak-Onurdag, Selda Ozgen

    A new series of 5-(p-substituted benzamido/phenylacetamido)-2-(p-tert-butylphenyl)benzoxazole derivatives were synthesized and evaluated for their antibacterial, antifungal, and antimycobacterial activities against antibiotic-resistant and -sensitive Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, and Mycobacterium tuberculosis as well as against Candida albicans and Candida krusei. The compounds possessed broad-spectrum activity against all of the tested Gram-positive and Gram-negative bacteria and yeasts, their minimum inhibitory concentrations (MICs) ranging between 16 - 128 μg/ml. One compound exhibited significant antibacterial activity (16 μg/ml) against an antibioticresistant Enterococcus faecalis isolate, having twice the potency of the compared standard drugs vancomycin and gentamycin sulfate. The compounds also showed moderate antitubercular activity with MIC values between 8 - 128 μg/ml against Mycobacterium tuberculosis and its clinical isolate.